All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

43

Reset

43 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AmlitelimabSAR445229Phase 39 trials

    Sanofi · Dermatitis Atopic, Coeliac Disease, Celiac Disease

  • FrexalimabSAR441344Phase 39 trials

    Sanofi · Multiple Sclerosis, Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

  • ItepekimabREGN3500, SAR440340Phase 39 trials

    Sanofi · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Bronchiectasis

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • DuvakitugSAR447189, TEV-48574 APhase 36 trials

    Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis

  • PCV21 vaccinePhase 35 trials

    Sanofi · Pneumococcal Immunization, Healthy Volunteers

  • SAR445088Riliprubart, BIVV020Phase 35 trials

    Sanofi · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic, Transplant Rejection

  • VenglustatGZ402671Phase 35 trials

    Sanofi · Fabry Disease, Gaucher's Disease Type III, Gaucher Disease Type 1

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • MenACYW conjugate vaccineNimenrixPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization

  • BIVV001efanesoctocog, AltuvoctPhase 33 trials

    Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe

  • bypassing agentsClotting factor concentrates, CFCPhase 33 trials

    Sanofi · Hemophilia, Von Willebrand Disease, Type 3

  • M-M-R II vaccinePhase 33 trials

    Sanofi · Pneumococcal Immunization

  • Sanofi · Multiple Sclerosis

  • poliomyelitis vaccinePhase 33 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Whooping Cough, Diphtheria

  • TolebrutinibSAR442168Phase 33 trials

    Sanofi · Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis

  • calcineurin inhibitorsPhase 32 trials

    Sanofi · Dermatitis Atopic

  • HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials

    Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers

  • IIV-HDstandalonePhase 32 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization

  • Sanofi · Multiple Sclerosis

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • EvorpaceptALX148Phase 25 trials

    ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic

  • ADG126Phase 23 trials

    Adagene Inc · Advanced/Metastatic Solid Tumors, Solid Tumor, Advanced Liver Cancers

  • Antithymocyte globulinATGPhase 22 trials

    Sanofi · Transplant Rejection, Renal Transplantation

  • Fluzone QudrivalentPhase 22 trials

    Sanofi · Healthy Volunteers, Influenza Immunization, Influenza

  • hMPV vaccinePhase 22 trials

    Sanofi · Human Metapneumovirus Immunization, Respiratory Syncytial Virus Immunization, Healthy Volunteers

  • Sanofi · Healthy Volunteers, Meningococcal Immunization, Meningococcal Immunisation

  • rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials

    Sanofi · COVID-19 Immunization, Influenza Immunization

  • RSV vaccine candidatePhase 22 trials

    Sanofi · Respiratory Syncytial Virus Infection, Healthy Volunteers, Respiratory Syncytial Virus Immunization

  • SAR445877Phase 22 trials

    Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma

  • SAR447537Phase 22 trials

    Sanofi · Alpha 1-Antitrypsin Deficiency, Emphysema

  • PegenzileukinSAR444245Phase 21 trial

    Sanofi · Plasma Cell Myeloma Refractory

  • SAR402663Phase 21 trial

    Sanofi · Neovascular Age-related Macular Degeneration

  • SAR439459Phase 21 trial

    Sanofi · Plasma Cell Myeloma Refractory

  • SAR441566Phase 21 trial

    Sanofi · Rheumatoid Arthritis

  • SAR443122Phase 21 trial

    Sanofi · Colitis Ulcerative

  • SAR444336Phase 21 trial

    Sanofi · Microscopic Colitis

  • SAR444836Phase 21 trial

    Sanofi · Phenylketonuria

  • SAR445399Phase 21 trial

    Sanofi · Hidradenitis Suppurativa

  • SAR446268Phase 21 trial

    Sanofi · Myotonic Dystrophy

  • SAR446597Phase 21 trial

    Sanofi · Geographic Atrophy

  • SAR448851Phase 21 trial

    Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.